The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) to set a negotiated price for

At no point on Thursday did anyone from the administration mention Medicare drug price negotiations, a key part of the Inflation Reduction Act which allows federal officials to negotiate the price of certain drugs. Trump has ridiculed the program, and no Republicans voted for the IRA when it passed in 2022.

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with obesity, President Trump announced on Thursday.

Novo Nordisk said on Wednesday it had agreed a price under the U.S. Medicare scheme for semaglutide, the active ingredient in its key drugs Ozempic and Wegovy, in a deal that some analysts said sounded less onerous than feared.

The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to consumers for as low as $149 per month, according to two people familiar with the negotiations.

WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price negotiations soon.

Topping the list are Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, which are considered one product in the talks since they all share the same active ingredient: semaglutide. Those treatments ...

A provision of the summer’s One Big Beautiful Bill Act bumping a slew of orphan drugs from Medicare price negotiation is estimated to cost the program $8.8 billion over the course of a decade, according to a revised estimate from the nonpartisan ...